You are here: Home Clinical Corner

Clinical Research

Pancreatic Proteolytic Enzyme Therapy Fails To Increase Survival or Quality of Life Compared to Conventional Gemcitabine Cytotoxic Therapy.

 E-mail | Print |

 ....those who chose gemcitabine-based chemotherapy survived more than three times as long (14.0 v 4.3 months) and had better quality of life than those who chose proteolytic enzyme treatment.

 

Methodology for Clinical Trials in Integrative Oncology by Andrew Vickers PhD.

 E-mail | Print | PDF 
 

Yoga Improves Pain and Fatigue

 E-mail | Print | PDF 

On the day after a day during which women practiced more yoga, they experienced significantly lower levels of pain and fatigue, and higher levels of invigoration, acceptance, and relaxation.

 

Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients.

 E-mail | Print | PDF 

Jinfukang did not alter the pharmacokinetics of docetaxel nor appear to affect survival in this study.

 

Evaluation of widely consumed botanicals as immunological adjuvants

 E-mail | Print | PDF 

Some, but not all, botanicals purported to be immune stimulants had adjuvant activity in our model. PSK and Astragalus were surprisingly active and are being further fractionated to identify the most active adjuvant components.

 
More Articles...
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3